Read whatthe sourceactually says.
A technical reference for seven peptide and small-molecule compounds — chemistry, manufacturing data, regulatory status by jurisdiction and documented safety signals. Every figure carries a primary source and the date it was checked. Where a value could not be verified, it is recorded as a gap rather than estimated.
Start here
Compounds covered
Grouped by the regulatory regime that applies to them, because that is what determines how each may lawfully be described. A compound authorised as a medicine and an ingredient assessed for cosmetic use are not the same kind of thing, and this reference does not present them as though they were.
Incretin therapeutics
Regulated as medicinal productsCompounds regulated as medicinal products. Authorisation status differs by jurisdiction, by brand and by route of administration, and one compound in this group holds no marketing authorisation anywhere.
- SemaglutideOzempic · Rybelsus · WegovyTechnical, analytical and regulatory reference for semaglutide as a manufactured peptide material across its injectable and oral routes.
- TirzepatideMounjaro · ZepboundTechnical, analytical and regulatory reference for tirzepatide as a manufactured synthetic peptide material.
- Orforglipronorforglipron calcium · orforglipron hemicalciumTechnical, analytical and regulatory reference for orforglipron as a manufactured small-molecule material.
- RetatrutideretatrutidumTechnical and regulatory reference for retatrutide, an investigational peptide holding no marketing authorisation in any jurisdiction.
Copper tripeptides
Regulated as cosmetic ingredientsCompounds regulated as cosmetic ingredients rather than as medicinal products. Ingredient safety assessment, not marketing authorisation, is the applicable regulatory framework, and no medicinal claims are made for them.
- GHK-CuCopper Tripeptide-1 · prezatide copper · glycyl-L-histidyl-L-lysine copper(II)Technical and cosmetic-regulatory reference for GHK-Cu as a manufactured cosmetic ingredient.
- AHK-CuL-alanyl-L-histidyl-L-lysine copper(II) · Cu(II)AHKTechnical and cosmetic-regulatory reference for AHK-Cu, a copper tripeptide for which registry identification and characterisation data are largely absent from primary sources.
Metabolic cofactors
No settled classificationCompounds with no settled regulatory classification across major jurisdictions. Classification varies by form and by route of administration, and remains contested in several territories.
What We Do
Engineering Biology at the Molecular Level
Chemistry, manufacturing and controls
Every compound entry is built on identity and specification data: molecular formula, registry identifiers, sequence and modifications, solubility, storage and the analytical methods used to confirm them. Where a figure is not published by a primary source, the field is recorded as unverified rather than filled.
Regulatory status by jurisdiction
Classification, authorised indication wording and marketing status recorded separately for each jurisdiction, because they differ. Indication text is quoted from the regulator that issued it, with the source document and the date it was last checked.
Manufacturing and wholesale supply
Peptide manufacturing and tableting for businesses, supplied for research and manufacturing purposes. Material is supplied against a specification, not a claim.
Our Edge
Why HelixEVO
Built from the ground up for B2B partners who demand precision, compliance, and results.
- Every data point carries a primary source and the date it was verified
- Vendor sites, blogs, forums and aggregators are excluded at parse time
- Unverifiable figures are recorded as gaps, never estimated
- Regulatory status recorded per jurisdiction, not generalised
- Contradictions between sources are preserved rather than reconciled
B2B Wholesale
Ready to Scale Your Peptide Product Line?
HelixEVO partners with health brands, clinics, and distributors to deliver finished, compliant peptide products at wholesale. Private label available.
Start a Wholesale Inquiry